Hemangioblastoma
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. (NCT04081701) | Weill Medical College of Cornell University | 2019-09-04 |
| Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease (NCT00970970) | University Medical Center Groningen | 2009-09-01 |
| Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma (NCT00589784) | Memorial Sloan Kettering Cancer Center | 2007-10-01 |
| Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow (NCT00330564) | M.D. Anderson Cancer Center | 2006-05-01 |
| Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease (NCT00005902) | National Institute of Neurological Disorders and Stroke (NINDS) | 2001-02-15 |
Track Hemangioblastoma automatically
Every clearance here is in the API, with alerts when new ones post.